| Literature DB >> 21660306 |
Sutapa Mondal Roy1, Munna Sarkar.
Abstract
Membrane fusion is a key event in many biological processes. These processes are controlled by various fusogenic agents of which proteins andEntities:
Year: 2011 PMID: 21660306 PMCID: PMC3108104 DOI: 10.1155/2011/528784
Source DB: PubMed Journal: J Lipids ISSN: 2090-3049
Figure 1Basic Steps of membrane fusion. (a) Membrane contact, (b) outer leaflet lipid mixing to form the hemifused state, and (c) inner leaflet lipid mixing and pore formation and content mixing.
Figure 2Different phases of lipid: (a) lamellar (L) phase and (b) inverted hexagonal (HII) phase.
Calculated amount of Ca2+ bound per PS in mixed PS/PC membranes [60].
| Vesicle composition (PS : PC) | Calculated tightly bound Ca2+ at various Ca2+ concentrations (in mM) | Na+ bulk concentration | |||||
|---|---|---|---|---|---|---|---|
| 0.7 | 1.0 | 2.0 | 3.0 | 5.0 | 10.0 | ||
| Pure PS | 0.44 | 0.44 | 0.44 | 0.44 | 0.45 | 0.45 | 5 |
| 4 : 1 | 0.43 | 0.43 | 0.44 | 0.44 | 0.44 | 0.44 | 5 |
| 2 : 1 | 0.42 | 0.43 | 0.44 | 0.44 | 0.44 | 0.44 | 5 |
| 3 : 2 | 0.41 | 0.41 | 0.42 | 0.42 | 0.43 | 0.43 | 5 |
| 1 : 1 | 0.40 | 0.40 | 0.41 | 0.42 | 0.43 | 0.43 | 5 |
| 2 : 3 | 0.38 | 0.39 | 0.40 | 0.40 | 0.41 | 0.42 | 5 |
| 1 : 4 | 0.32 | 0.33 | 0.35 | 0.36 | 0.37 | 0.38 | 5 |
|
| |||||||
| Pure PS | 0.32 | 0.35 | 0.38 | 0.39 | 0.41 | 0.43 | 100 |
| 4 : 1 | 0.30 | 0.33 | 0.36 | 0.38 | 0.40 | 0.42 | 100 |
| 2 : 1 | 0.28 | 0.32 | 0.35 | 0.37 | 0.39 | 0.41 | 100 |
| 3 : 2 | 0.27 | 0.31 | 0.34 | 0.36 | 0.38 | 0.40 | 100 |
| 1 : 1 | 0.25 | 0.29 | 0.33 | 0.35 | 0.37 | 0.39 | 100 |
| 2 : 3 | 0.23 | 0.26 | 0.31 | 0.33 | 0.35 | 0.38 | 100 |
| 1 : 4 | 0.15 | 0.19 | 0.24 | 0.26 | 0.30 | 0.34 | 100 |
|
| |||||||
| Pure PS | 0.11 | 0.16 | 0.21 | 0.25 | 0.29 | 0.34 | 500 |
| 4 : 1 | 0.10 | 0.14 | 0.20 | 0.23 | 0.27 | 0.33 | 500 |
| 2 : 1 | 0.09 | 0.12 | 0.18 | 0.22 | 0.26 | 0.32 | 500 |
| 3 : 2 | 0.08 | 0.12 | 0.17 | 0.21 | 0.25 | 0.31 | 500 |
| 1 : 1 | 0.07 | 0.11 | 0.16 | 0.19 | 0.24 | 0.30 | 500 |
| 2 : 3 | 0.06 | 0.09 | 0.14 | 0.18 | 0.22 | 0.28 | 500 |
| 1 : 4 | 0.04 | 0.06 | 0.10 | 0.13 | 0.18 | 0.25 | 500 |
Figure 3Binding of Ca2+ with PS headgroup.
Figure 4Sulfatide.
Figure 5Schematic diagram of the partition breakage model. The arrows in (1) show the La3+-induced lateral compression pressure of the membranes, and the green triangle in (2) shows the interstitial hydrocarbon region where free energy of chain packing is very large. Adapted from reference [64].
Figure 6n-hexyl bromide.
Figure 7Ethanol.
Figure 8Abscisic Acid.
Figure 9Halothane.
Figure 10Oxicam NSAIDs: meloxicam (a), piroxicam (b) and tenoxicam (c).
Figure 11Chlorpromazine.
Relation of the fusogenic molecules with its threshold concentration and size. For the determination of the length and width of the molecules, all the geometries are minimized using a semiempirical level of theory, Austin Model 1 (AM1) using GAUSSIAN 03 [128]. AM1 is based on a modified neglect of differential overlap (MNDO) approximation [129].
| Molecules | Length (in nm) | Width (in nm) | Molecule-to-lipid ratio at threshold concentration | Vesicle size |
|---|---|---|---|---|
| Abscisic acid | 1.04 | 0.68 | 0.125 | MLV ( |
|
| 0.88 | 0.25 | 0.050 | SUV (30–40 nm) |
| Ethanol | 0.40 | 0.23 | ||
| Halothane | 0.42 | 0.30 | 10.0 | LUV ( |
| Meloxicam | 1.43 | 0.60 | 0.018 | SUV (50–60 nm) |
| Piroxicam | 1.38 | 0.61 | 0.018 | SUV (50–60 nm) |
| Tenoxicam | 1.23 | 0.54 | 0.018 | SUV (50–60 nm) |
| Chlorpromazine | 1.06 | 1.01 | 6000–8000 nm |
Figure 12Ibuprofen.